Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.
about
Integration and comparison of different genomic data for outcome prediction in cancer.The challenge of triple negative breast cancersPrediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.Filter-Dense Multicolor MicroscopyRecent progress in protein profiling of clinical tissues for next-generation molecular diagnostics.4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.Using second harmonic generation to predict patient outcome in solid tumors.Global proteomic characterization of microdissected estrogen receptor positive breast tumors.The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies.Lymph node metastasis of primary endometrial cancers: Associated proteins revealed by MALDI imaging.Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformationPrediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples.Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.Is label-free LC-MS/MS ready for biomarker discovery?Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.Protein biomarkers for subtyping breast cancer and implications for future research.
P2860
Q31013326-6B971372-BEDB-44FF-88BD-D9C716AA813DQ33774570-C8D32CD5-9D88-4D98-8AAC-2A53CD6E4D01Q33778306-48577F7E-ED38-48FE-B842-617789393792Q33850657-4692C75D-1766-46AC-B01F-D9D12E2D2661Q35571593-9CB26862-2AC3-4CE0-AC97-409358A058FFQ35714211-6EB5F5C4-CDE3-4E64-A18D-797134CA31ECQ35749170-A1E81C9F-946E-4149-8935-1DA6A3DDDB59Q35851755-D5693891-8E4F-4058-92C0-F854C00D5B1FQ35950715-417DCC60-F500-426E-8075-E16155736FEEQ35974746-3DED8097-B718-4D97-9B10-A1AE38D36A9FQ35984477-766ED012-5E1F-4F96-A2FD-165E3C251357Q36241768-12D877D5-A10D-49F2-AE98-497089AB4C22Q36263017-58716DF3-05F2-4622-9633-1CB775B81896Q36772047-143839BF-9ED0-4A33-A90C-AEB648D3F049Q37054767-C6042A3B-6D3E-462D-9CFC-0375AA007CF1Q37077443-EC298A3E-9145-4FFA-B6B6-1FD8F4B029E2Q37202473-BF271923-8D08-4B4E-ACFB-F14C33BA401FQ38345838-FEF6EAFB-549D-495C-8F13-95DB14922F83Q39000232-CD1603C3-30CC-4219-960C-E238D0602EE2Q39021766-E459A6A2-5C6B-4920-AC1F-1136BA375B80Q42511387-A3A7776E-9CE7-40E9-8BD2-BE20AB474756Q47261659-4D4F7F86-FC74-47E8-B22C-55AC66C0FAF7
P2860
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative proteome analysis ...... triple-negative breast cancer.
@en
Comparative proteome analysis ...... triple-negative breast cancer.
@nl
type
label
Comparative proteome analysis ...... triple-negative breast cancer.
@en
Comparative proteome analysis ...... triple-negative breast cancer.
@nl
prefLabel
Comparative proteome analysis ...... triple-negative breast cancer.
@en
Comparative proteome analysis ...... triple-negative breast cancer.
@nl
P2093
P2860
P50
P356
P1476
Comparative proteome analysis ...... triple-negative breast cancer.
@en
P2093
Angelo Paradiso
Anieta M Sieuwerts
Christoph Stingl
John A Foekens
John W M Martens
Luc Y Dirix
Marcel Smid
Maxime P Look
Ning Qing Liu
P2860
P304
P356
10.1093/JNCI/DJT376
P407
P577
2014-01-07T00:00:00Z